地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:17754422825
邮箱:sales@amyjet.com
<艾美捷科技代理AkrivisBio品牌全系列产品
AkrivisBio是生命科学与生物技术领域的研究产品供应商,公司名"Akrivis"源自古希腊语,意为"精准",彰显企业核心理念;"Bio"则界定我们其专业领域。AkrivisBio公司的核心产品线包括细胞增殖与毒性检测平台、代谢分析系统、样品分离与制备试剂盒、专业染色试剂盒以及生化试剂系列。

▎AkrivisBio产品线
●检测试剂盒(部分产品列表)
①细胞增殖与毒性检测:AkrivisBio公司提供多种细胞毒性及增殖检测方案,包括用于药物筛选的MTT法、MTS法和LDH检测法。我们的试剂盒操作简单、高效便捷,可兼容多种样本类型。
②代谢分析:AkrivisBio公司提供涵盖碳水化合物代谢、脂质代谢、氨基酸合成等多条通路的代谢检测试剂盒,用于精准定量代谢物、分析物及中间产物。试剂盒具有精度高、速度快、操作简便等优势,适用于各类样本,并兼容酶标仪、荧光酶标仪及分光光度计等常用检测设备。
③样品分离与制备试剂盒:产品线包含:细胞器分离富集试剂盒(线粒体、溶酶体等)、细胞组分分离试剂盒(细胞核、胞质蛋白、膜蛋白等)、以及TCA/PCA/SSA去蛋白试剂盒(用于分析前去除样本蛋白质)。这些试剂盒提供便捷高效的样本处理方案,分离后的样本可完美适配Western blot等下游应用。
④染色试剂盒:通过特异性染料或抗体标记目标分子,实现DNA、蛋白质、脂质、细胞器及特定标志物的可视化观测。AkrivisBio公司提供脂质染色试剂盒、细胞活性/毒性双染试剂盒、β-半乳糖苷酶染色试剂盒等系列产品,满足各类研究需求。
| 品名 | 货号 | Size |
| LDH Based Cell Cytotoxicity Assay | CPT-0101 | Includes reagents for 500 wells |
| Crystal Violet Cell Cytotoxicity Assay | CPT-0102 | Includes reagents for 1000 wells |
| MTT Cell Proliferation Assay | CPT-0103 | Includes reagents for 1000 wells |
| MTS Cell Proliferation Assay | CPT-0104 | Includes reagents for 2500 wells |
| Quick Cell Proliferation Assay | CPT-0105 | Includes reagents for 500 and 2500 wells |
| Ready-to-use Cell Proliferation Reagent | CPT-0106 | Includes reagents for 2500 wells |
| Neutral Red Cell Cytotoxicity Assay | CPT-0107 | Includes reagents for 1000 wells |
| Oil Red O Lipid Staining Kit | COS-0101 | To stain two plates (6- 12-, 24- or 96-well) or five 100 mm culture dishes |
| Senescence Staining Assay | COS-0102 | To stain 4X 24-, 12-, 6-well plates |
| Live vs. Dead Cell Differentiation Staining Kit | COS-0103 | Includes reagent for staining 4 x 24-well plates. |
| Beta-galactosidase Staining Kit | COS-0104 | Includes reagents to stain 20 x 12-well plates or the equivalent volume of 6 or 24-well plates. |
| Alkaline Phosphatase Staining Kit | COS-0105 | Includes reagents to stain 96-, 48-, 24-, 12-, 6-well plates |
| Cell-Based Lysosomal Cytotoxicity Dual Staining Kit | COS-0106 | 50 assays |
| CaspACTIV Active Caspase-9 Staining Kit | COS-0107 | 25 wells, 100 wells |
| Annexin V-FITC Apoptosis Detection Kit | COS-0108 | 25 wells, 100 wells |
| Protein Myristoylation Assay | COS-0109 | 100 wells |
●即用型微孔板
| 品名 | 货号 | Size |
| Glucose RediPlate | RP-0122C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Pyruvate Kinase RediPlate | RP-0107C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Alkaline Phosphatase Activity Assay | RP-0109C | 480 wells |
●生化试剂(部分产品列表)
| 品名 | 货号 | CAS号 | 分子式 |
| 2-Hexyl-4-Pentynoic Acid | B2834 | 96017-59-3 | C₁₁H₁₈O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Destruxin A | B2947 (Copy) | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| DTBA | B3242 | 1363376-98-0 | C₄H₁₁NS₂·HCl |
| Telotristat | B338 | 1033805-28-5 | C₂₅H₂₂ClF₃N₆O₃ |
| AZD-4573 | B3319 | 2057509-72-3 | C₂₂H₂₈ClN₅O₂ |
| Eltoprazine hydrochloride | B2301 | 98206-09-8 | C₁₂H₁₆N₂O₂HCl |
| 3-TYP | B2322 | 120241-79-4 | C₇H₆N₄ |
| LY-2510924 | B2360 | 1088715-84-7 | C₆₂H₈₇N₁₃O₁₁ |
| Salermide | 1873 | 1105698-15-4 | C₂₆H₂₂N₂O₂ |
| Atractyloside Potassium Salt | B2441 | 102130-43-8 | C₃₀H₄₄K₂O₁₆S₂ |
| PZ-2891 | B2460 | 2170608-82-7 | C₂₀H₂₃N₅O |
| Lanreotide Acetate | B2464 | 127984-74-1 | C₅₄H₆₉N₁₁O₁₀S₂ · xC₂H₄O₂ |
| Vesatolimod | B2555 | 1228585-88-3 | C₂₂H₃₀N₆O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Sodium dichloroacetate | B3080 | 2156-56-1 | C₂HCl₂NaO₂ |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Pibrentasvir | B2168 | 1353900-92-1 | C₅₇H₆₅F₅N₁₀O₈ |
| STF-62247 | B2210 | 315702-99-9 | C₁₅H₁₃N₃S |
| Anastrozole | B2177 | 120511-73-1 | C₁₇H₁₉N₅ |

BioVision公司是世界顶尖的细胞凋亡和信号传导产品生产商,产品包括检测试剂盒,抗体及重组蛋白,涵盖了细胞凋亡、细胞信号传导和细胞因子研究的各个方面。凋亡产品包括Annexin V 试剂盒、半胱天冬氨酸蛋白酶(Caspases)试剂盒及底物和抑制剂、线粒体膜电位试剂盒、梯状DNA 电泳和TUNEL 试剂盒、凋亡诱导剂、凋亡相关抗体和化学品、细胞增殖检测试剂盒等。
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.
BioVision公司的主要产品包括:
Antibodies & Supporting Tools
Biochemicals
Cytokines & Growth Factors
ELISA Kits
Enzyme Inhibitors
EZSolution™ Ready-to-Use Products
Fluorescent Proteins
Laboratory accessories
Metabolism Assay Kits
Molecular Biology
Protein A,G,L & Affinity Conjugates
Proteins & Enzymes
Protein Extraction & Purification
Signaling Pathways
按研究领域细分
Apoptosis
Autophagy
Cardiovascular
Cancer
Cell Damage & Oxidative Stress
Cell Proliferation, Viability & Cytotoxicity
Diabetes, Obesity & Metabolic Syndrome
Drug Metabolism & Disposition
Epigenetics
Exosomes
Infectious Diseases
Metabolism
Neuroscience
Proteostasis
Signal Transduction
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioVision"> BioVision
艾美捷科技特约代理Atlas Antibodies抗体产品。
Atlas Antibodies公司开发与人类蛋白有关的抗体以及试剂,基于质谱(MS)的定量蛋白质组学,在人体中可能的20,000种蛋白质编码基因中,Atlas已经具有覆盖15,000种的基因产物,超过17,000种抗体,约13,000种蛋白质靶标。
At Atlas Antibodies we have a very clear mission: To provide our customers with advanced research reagents targeting all human proteins. The Human Protein Atlas (HPA) project released the first version of a complete tissue-based map of human protein expression using antibodies in November 2014. In close partnership with the HPA project, we continue to develop advanced antibodies and advanced reagents for Mass Spectrometry (MS)-based quantitative proteomics. Of the possible 20,000 protein coding genes in the human body we already have over 21,000 antibodies covering 15,000 gene products. Learn more in this in the video below.
Atlas Antibodies公司的主要产品包括:
Primary Antibodies
All Primary Antibodies
Triple A Polyclonals
PrecisA Monoclonals
Blocking Antigens
MS Standards
QPrESTs
Laminin Markers
Neuroscience Markers
EMT Markers
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Atlas Antibodies"> Atlas Antibodies
成立30多年来,KRONUS公司专注于向世界范围内研究机构提供免疫检测试剂盒。该公司产品涉及的研究领域包括胰岛细胞自身免疫性、神经免疫学、甲状腺癌、肾上腺自身免疫性等。
For over 30 years, KRONUS has provided specialized immunoassay test kits to medical professionals at the world's most respected laboratory facilities. Please contact us directly with any questions, requests or comments that you may have. We welcome the opportunity to learn how we can be of assistance in meeting your laboratory's immunoassay test kit needs.
KRONUS的主要产品包括:
Acetylcholine Receptor
Antibody (AChRAb)
Binding Antibody
Blocking Antibody
Aquaporin-4 Autoantibody
Glutamic Acid Decarboxylase
(GADAb) Antibody
Zinc-Transporter Antibody
IA-2 Antibody
Insulin Autoantibody
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Kronus"> Kronus
艾美捷科技代理LifeSensors品牌。
LifeSensors成立于1996年,位于美国宾夕法尼亚州费城,是一家为药物发现与研究提供方法和可行性技术方法的生物技术公司。公司致力于为泛素和泛素蛋白酶体通路研究领域提供高品质
的抗体、酶、蛋白质等试剂和试剂盒,产品,是泛素研究者的好选择。
其原核和真核蛋白表达系统SUMOpro和SUMOstar已被世界范围内的学术、政府研究机构和制药、生物技术公司广泛应用。通过提供创新的研究工具,LifeSensors已成为泛素和泛素样蛋
白途径的优质供应商。
LifeSensors公司目前主要的产品有400多种,其产品主要覆盖泛素和泛素蛋白酶体通路等科学应用领域,并且产品线在不断的扩大中。公司开创了两大独家技术平台:用于细胞信号和药物
发现的泛素蛋白酶体系统(UPS),以及增强目的蛋白在大肠杆菌、酵母、昆虫和哺乳动物细胞中表达与纯化的SUMO融合表达系统。泛素蛋白酶体系统正在成为继激酶之后,药物发现的下
一个机遇,必将成为未来许多新型药物的创新来源。作为泛素蛋白领域的先驱公司,药物的发现、分析化合物以及去泛素酶和泛素化酶的高通量筛选正是LifeSensors创新技术的真正亮点。
此外,LifeSensors还为泛素的蛋白质组学提供众多定制技术服务,并且已经开发了各种各样的测定细胞中的生理底物或生物标志物的方法。
< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理LifeSensors品牌"> 艾美捷科技代理LifeSensors品牌
艾美捷科技特约代理Alpco全系列产品
Alpco公司从成立初期就致力于生物医药领域各种免疫检测试剂盒的研发与生产,力求为广大客户提供高质量的免疫检测产品。ALPCO产品种类多样,可测样品来源包括人、大/小鼠、豚鼠、兔、猪、羊、狗、猴等,涉及神经生物学、骨代谢、心血管疾病和氧化应激、细胞因子与信号转导、糖尿病和肥胖症、内分泌学、甲状腺功能、肠胃病学、免疫学、生殖激素、抗体和抗原、分子诊断等多个研究领域,尤以糖尿病和肥胖症研究领域见长。
ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.
Alpco公司的主要产品包括:
Immunoassays
Flow Cytometry
HPLC/LC-MS
Chemiluminescence
按照研究领域细分
Antibodies & Antigens
Allergy & Infectious Disease
Bone Metabolism
CVD & Oxidative Health
Diabetes & Obesity
Endocrinology
Gastroenterology
Immunology
Neurobiology
Toxicology
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Alpco全系列产品"> 艾美捷科技特约代理Alpco全系列产品
Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |

PhytoTechnology(简称PhytoTech)公司是一家专门从事于研发和生产植物组织培养基,植物学技术相关产品的一家科研生产性企业。由Dr. Kenneth C. Torres博士和他的妻子Janet 于1997年在美国Lenexa, Kansas州创立,随着公司产品的不断改进和更新,目前PhytoTech公司已经成为了世界上著名的植物生物学类产品的生厂商和原料供应商,其公司产品以稳定的质量和优质的价格已赢得了世界范围内众多客户的认可,并在植物学的各个领域内广泛使用。
PhytoTechnology Laboratories manufactures and distributes products to the plant tissue culture, plant biotechnology, and plant science markets. Our products are used to mass propagate plants on sterile culture media in laboratory settings. We also supply products for the genetic improvement of plants through gene transformation research. Manufacturing, product development, administration and distribution of products are all performed at the PhytoTechnology Laboratories campus (20,000 square feet of production and research and development space) in Overland Park, a suburb of the Kansas City metro area in Kansas. This central US location provides direct access to most major markets around the world.
PhytoTechnology公司主要产品包括:
Plant Media
Biochemicals
Molecular Biology
Microbiology
Phytopathology
Phycology
Seed Testing
Kits Equipment
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
<艾美捷科技代理Arraybridge品牌全系列产品
Array Bridge 公司由一群在药物发现与生物制品开发领域经验丰富的科学家创立。公司专注于两大方向:生物制品开发与功能蛋白质组学。在生物制品领域,Array Bridge 开发了 "蛋白质构象阵列"(Protein Conformational Array)技术,可在分子层面对生物类似药及新型生物制品的结构相似性进行精准测量,为生物制剂的构象可比性提供高灵敏、系统性且稳健的评估方案。在功能蛋白质组学方向,公司创新推出PEP(蛋白质洗脱板,Protein Elution Plate)技术,该系统通过整合高效的蛋白质洗脱与重折叠流程,实现了对蛋白质组功能性蛋白的系统性检测。该技术融合了二维凝胶蛋白质分离的高分辨率优势,成为绘制功能性蛋白质组图谱的强大工具。

▍Arraybridge产品线
Array Bridge公司的核心产品包括蛋白组学PEP试剂盒、生物标志物发现、单克隆抗体构象分析、蛋白纯化、检测试剂以及酶活性检测产品。
● 蛋白组学PEP试剂盒
| 品名 | 中文名称 | 货号 |
| NADPH Oxidases Landscape (Large Format PEP) | NADPH 氧化酶组的系统分析(大规格的PEP 平板)试剂盒 | AB000503 |
| NADH Oxidases Landscape (Large Format PEP) | NADH 氧化酶组的系统分析(大规格的PEP 平板)试剂盒 | AB000502 |
| Protein Kinases Landscape (Large Format PEP) | 蛋白激酶组的系统分析(大规格的PEP 平板)试剂盒 | AB000504 |
| Proteinases Landscape (Large Format PEP) | 蛋白酶组的系统分析(大规格的PEP 平板)试剂盒 | AB000505 |
| Proteinases Connect (Small Format PEP) | 蛋白酶族的系列分析(小规格的PEP)试剂盒 | AB000405 |
| Protein Kinases Connect (Small Format PEP) | 蛋白激酶族的系列分析(小规格的PEP)试剂盒 | AB000404 |
| NADH Oxidases Connect (Small Format PEP) | NADH 氧化酶族的系列分析(小规格的PEP)试剂盒 | AB000402 |
| NADPH Oxidases Connect (Small Format PEP) | NADPH 氧化酶族的系列分析(小规格的PEP)试剂盒 | AB000403 |
● 生物标志物发现
<| 品名 | 货号 |
| UPCK Buffer Kit (500 & 1000 ml) | AB000625-500 |
| UPCK Elution Buffer UPEB™ (500 & 1000 ml) | AB000624-500 |
| UPCK Wash Buffer UPWB™ (500 & 1000 ml) | AB000623-500 |
| UPCK Binding Buffer UPBB™ (500 & 1000 ml) | AB000622-500 |
| Hemovoid Buffer Kit (500 & 1000 ml) | AB000621-500 |
| HemoVoid Elution Buffer HVEB™ (500 & 1000 ml) | AB000620-500 |
| HemoVoid Wash Buffer HVWB™ (500 & 1000 ml) | AB000619-500 |
| HemoVoid Binding Buffer HVBB™ (500 & 1000 ml) | AB000618-500 |
| AlbuVoid Buffer Kit (500 & 1000 ml) | AB000617-500 |
| AlbuVoid Elution Buffer AVEB™ (500 & 1000 ml) | AB000616-500 |
| AlbuVoid Wash Buffer AVWB™ (500 & 1000 ml) | AB000615-500 |
| AlbuVoid Binding Buffer AVBB™ (500 & 1000 ml) | AB000614-500 |
| KinaSorb™ (10 & 50 Preps) | AB000612-10 |
| UPCK™ Urine Protein Concentration Kit (10 & 25 Preps) | AB000611-10 |
| Hemo Trial Kit™ | AB000606 |
| HemoVoid™ - Blood Card Reagent (10 & 50 Dried Whole Blood Card) | AB000609-10 |
| HemoVoid™ (10, 50 & 100 Preps) | AB000608-10 |
| HemogloBind™ (15 & 50 ml) | AB000607-15 |
| Cleanascite™ | AB000605-100 |
| BindPro™ Metabolomics (15 & 50 Preps) | AB000604-15 |
| AlbuVoid™ (10 & 50 Preps) | AB000603-10 |
| AlbuSorb™ (6 & 18 grams) | AB000602-6 |
| Albu Trial Kit™ | AB000601 |
| P53Bridge ELISA Kit | AB000219 |
| SHP2Bridge ELISA Kit | AB000220 |
● 单克隆抗体构象分析
<| 品名 | 货号 |
| OmaBridge Elisa Kit | AB00023 |
| SomaBridge ELISA Kit | AB000217 |
| RabBridge ELISA Kit | AB000222 |
| MouseBridge ELISA Kit | AB000221 |
| AfliBridge ELISA Kit (for Eylea Biosimilar Comparison) | AB000218 |
| UsteBridge ELISA Kit (for Stelara Biosimilar Comparison) | AB000216 |
| GoliBridge ELISA Kit (for Simponi Biosimilar Comparison) | AB000215 |
| DenoBridge ELISA Kit (Prolia Biosimilar Comparison) | AB000213 |
| LuceBridge ELISA (for Lucentis Biosimilar Comparision) | AB000214 |
| FilBridge ELISA (For Filgrastim Biosimilar Comparison) | AB000212 |
| EnbrBridge Elisa (for Enbrel biosimilar comparison) | AB000211 |
| EpoBridge ELISA (for Erythropoietin Biosimilar comparison) | AB000210 |
| RituBridge ELISA (for Rituxan Biosimilar Comparison) | AB000204 |
| RemiBridge ELISA (for Remicade Biosimilar comparison) | AB000209 |
| ErbiBridge ELISA (for Erbitux Biosimilar Comparison) | AB000202 |
| CampBridge ELISA (for Campath Biosimilar Comparison) | AB000203 |
| InnoBridge ELISA (for novel monoclonal antibody & other biosimilars with the same Fc sequence) | AB000208 |
| HercBridge ELISA (for Herceptin Biosimilar Comparison) | AB0002071 |
| SynaBridge ELISA (for Synagis Biosimilar Comparison) | AB000206 |
| HumiBridge ELISA (for Humira Biosimilar Comparison) | AB000205 |
| AvaBridge ELISA (for Avastin Biosimilar Comparison) | AB000201 |
● 蛋白纯化
| 品名 | 中文名称 | 货号 |
| PEP Universal Protein Purification Kit -- Large Format | 蛋白纯化(大规格的PEP 平板)试剂盒 | AB000501 |
| PEP Universal Protein Purification Kit -- Small Format | 384 孔通用PEP 平板功能蛋白质纯化试剂盒 | AB000401 |
● 检测试剂
<| 品名 | 货号 | 产品描述 |
| SHP2 ELISA | AB000127 | For the quantitation of SHP2 protein from human tissue, cell lines and other samples (Catalog #: AB000127) |
| P53 ELISA | AB-000126 | For the determination of p53 protein from human tissue, cell lines and other samples (Catalog #: AB000126) |
| Anti-human IgG ELISA Kit | AB000303 | The anti-human IgG ELISA kit is designed to quantitatively measure human IgG levels in biological samples. |
| Horse Radish Peroxidase (HRP) stabilizer (50 ml) | AB000804 | For the stabilization and long term storage of low and high concentrations of Horse Radish Peroxidase (Catalog # AB000804) |
| One-Step TMB substrate (250 ml) | AB000801 | For easy detection of HRP activities in ELISA analysis (Catalog # AB000801) |
| One-Step Enhanced TMB substrate (250 ml) | AB000802 | For highly sensitive detection of HRP activities (Catalog # AB000802) |
| ELISA plate stabilizer (1000 ml) | AB000803 | For the long term stabilization of coated ELISA plates (Catalog # AB000803) |

艾美捷科技特约代理EdgeBio公司产品。
EdgeBio公司拥有一批经验丰富的专业研究人员,专注于研发下一代测序技术及应用。
EdgeBio has a team of experienced research professionals that are knowledgeable in next generation sequencing technologies and applications. From library preparation through data analysis, EdgeBio representatives are there to discuss your project on a custom basis to ensure that you receive the results you need for your research.
EdgeBio公司的主要产品包括:
Accessories
Sequencing Clean-Up
PCR Purification
Sample Preparation
Competent Cells
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="EdgeBio"> EdgeBio地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:13212737804
传真:13212737804
邮箱:sales@amyjet.com
0.2843